Jaroslav Štěrba
- Molecular Biology
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Neurology top 5%
- Public Health, Environmental and Occupational Health top 10%
- Co-authors
- Renata VeselskáPavel MazánekKarel ZitterbartDalibor ValíkPetr ChlapekJakub NeradilZdeněk PavelkaPeter Múdrý
- Topics
- Acute Lymphoblastic Leukemia research (23 papers)Childhood Cancer Survivors' Quality of Life (19 papers)Glioma Diagnosis and Treatment (16 papers)
- Cited by
- GeneticsOncologyHematology
- Partner nations
- CzechiaUnited StatesGermany
In The Last Decade
Jaroslav Štěrba
136 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 121
- Molecular Biology 604
- Oncology 469
- Pulmonary and Respiratory Medicine 252
- Neurology 238
- Public Health, Environmental and Occupational Health 219
Countries citing papers authored by Jaroslav Štěrba
This map shows the geographic impact of Jaroslav Štěrba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaroslav Štěrba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaroslav Štěrba more than expected).
Fields of papers citing papers by Jaroslav Štěrba
This network shows the impact of papers produced by Jaroslav Štěrba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaroslav Štěrba. The network helps show where Jaroslav Štěrba may publish in the future.
Co-authorship network of co-authors of Jaroslav Štěrba
This figure shows the co-authorship network connecting the top 25 collaborators of Jaroslav Štěrba. A scholar is included among the top collaborators of Jaroslav Štěrba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaroslav Štěrba. Jaroslav Štěrba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 8 | |
| 7 | 0 | |
| 8 | 2 | |
| 9 | 1 | |
| 10 | 7 | |
| 11 | 9 | |
| 12 | Vitamin D – jeho fyziologie, patofyziologie a význam vetiopatogenezi nádorových onemocnění | 0 |
| 13 | BAFF Levels Are Elevated in Paediatric Patients With Acute Lymphoblastic Leukaemia Compared to Other B-Lineage Neoplasms | 3 |
| 14 | Quality of life of childhood cancer survivors: handicaps andbenefits | 4 |
| 15 | 42 | |
| 16 | Následky léčby dětských nádorových onemocnění v oblasti neurokognitivních funkcí a jejich vliv na kvalitu života. | 1 |
| 17 | Kvalita života dětí po léčbě nádorového onemocnění: současnépoznatky a směry výzkumu. | 1 |
| 18 | 1 | |
| 19 | Tissue reaction of the liver of cattle to an artificial or natural infection with Cysticercus bovis. | 2 |
| 20 | Experimental studies on bovine cysticercosis | 6 |
About Jaroslav Štěrba
Jaroslav Štěrba is a scholar working on Genetics, Oncology and Hematology, having authored 148 papers that have together received 1.7k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (23 papers), Childhood Cancer Survivors' Quality of Life (19 papers) and Glioma Diagnosis and Treatment (16 papers). The work is most often cited by research in Genetics (208 citations), Oncology (469 citations) and Hematology (191 citations). Jaroslav Štěrba has collaborated with scholars based in Czechia, United States and Germany. Frequent co-authors include Renata Veselská, Pavel Mazánek, Karel Zitterbart, Dalibor Valík, Petr Chlapek, Jakub Neradil, Zdeněk Pavelka, Peter Múdrý, Viera Bajčiová and Regina Demlová. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.